INTERNATIONAL PATENT: MEMORIAL SLOAN-KETTERING CANCER CENTER, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES, SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH FILES APPLICATION FOR "LINEAGE PERTURBATION THERAPY METHODS INCLUDING LATS1/2 KINASE INHIBITORS AND TIP60 INHIBITORS"

GENEVA, May 13 -- MEMORIAL SLOAN-KETTERING CANCER CENTER (1275 York AvenueNew York, New York 10065), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (1275 York AvenueNew York, New York 10065), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (1275 York AvenueNew York, New York 10065) filed a patent application (PCT/US2025/053362) for "LINEAGE PERTURBATION THERAPY METHODS INCLUDING LATS1/2 KINASE INHIBITORS AND TIP60 INHIBITORS" on Oct 30, 2025. With publication no. WO/2026/096780, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor...